BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37993904)

  • 1. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome.
    Amin M; Gragnoli C
    J Ovarian Res; 2023 Nov; 16(1):222. PubMed ID: 37993904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin receptor (OXTR) is a risk gene for polycystic ovarian syndrome.
    Amin M; Horst N; Wu R; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2634-2639. PubMed ID: 37013781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mineralocorticoid receptor gene (NR3C2) is linked to and associated with polycystic ovarian syndrome in Italian families.
    Amin M; Perrelli M; Wu R; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):942-948. PubMed ID: 36808340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome.
    Amin M; Horst N; Wu R; Gragnoli C
    J Ovarian Res; 2023 Aug; 16(1):155. PubMed ID: 37543650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucocorticoid receptor gene (NR3C1) is linked to and associated with polycystic ovarian syndrome in Italian families.
    Syed S; Gragnoli C
    J Ovarian Res; 2024 Jan; 17(1):13. PubMed ID: 38217051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The melatonin receptor genes are linked and associated with the risk of polycystic ovary syndrome.
    Postolache TT; Al Tinawi QM; Gragnoli C
    J Ovarian Res; 2024 Jan; 17(1):17. PubMed ID: 38217063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between prolactin receptor expression and proliferation in the endometrium of obese women with polycystic ovary syndrome.
    Paulson M; Norstedt G; Sahlin L; Hirschberg AL
    Gynecol Endocrinol; 2020 Mar; 36(3):226-232. PubMed ID: 31389293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic Ovary Syndrome in Adolescents.
    Witchel SF; Roumimper H; Oberfield S
    Endocrinol Metab Clin North Am; 2016 Jun; 45(2):329-44. PubMed ID: 27241968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide linkage and association study identifies novel genes and pathways implicated in polycystic ovarian syndrome.
    Amin M; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3719-3732. PubMed ID: 37140321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome.
    Amin M; Horst N; Gragnoli C
    J Ovarian Res; 2023 Aug; 16(1):158. PubMed ID: 37563671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel linkage and association of TCF7L2 variants with PCOS in Italian families.
    Amin M; Del Bosque-Plata L; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7346-7351. PubMed ID: 37606143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
    Siddiqui S; Mateen S; Ahmad R; Moin S
    J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.